These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 397957)

  • 1. Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review.
    Mori T; Nagasawa H; Bern HA
    J Environ Pathol Toxicol; 1979 Dec; 3(1-2):191-205. PubMed ID: 397957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of neonatal hormonal treatments on plasma prolactin levels in female BALB/cfC3H and BALB/c mice.
    Nagasawa H; Mori T; Yanai R; Bern HA; Mills KT
    Cancer Res; 1978 Apr; 38(4):942-5. PubMed ID: 639048
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice.
    Jones LA; Bern HA
    Cancer Res; 1977 Jan; 37(1):67-75. PubMed ID: 830422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of mouse mammary glands after neonatal sex hormone treatment.
    Tomooka Y; Bern HA
    J Natl Cancer Inst; 1982 Dec; 69(6):1347-52. PubMed ID: 6958910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of prenatal and neonatal administration of 5beta-dihydrotestosterone on normal and neoplastic mammary development in mice.
    Yanai R; Mori T; Nagasawa H
    Cancer Res; 1977 Dec; 37(12):4456-9. PubMed ID: 200350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
    Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
    In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of neonatal steroid exposure on mammary gland development and tumorigenesis in mice.
    Mori T; Bern HA; Mills KT; Young PN
    J Natl Cancer Inst; 1976 Nov; 57(5):1057-62. PubMed ID: 187788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sex steroids and prolactin on rat mammary gland.
    Srinivasan N; Govindarajulu P; Vanithakumari G
    Indian J Physiol Pharmacol; 1980; 24(4):322-8. PubMed ID: 7216387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal effects on rat mammary gland in vitro.
    Peters JM; van Marle J; Ariëns AT
    Acta Endocrinol Suppl (Copenh); 1979; 228():1-190. PubMed ID: 229688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of hormones on DNA synthesis in cell cultures of nonneoplastic and neoplastic mammary epithelium from rats.
    Hallowes RC; Rudland PS; Hawkins RA; Lewis DJ; Bennet D; Durbin H
    Cancer Res; 1977 Aug; 37(8 Pt 1):2492-504. PubMed ID: 872078
    [No Abstract]   [Full Text] [Related]  

  • 12. Difference in response to mammotropic hormones of mammary growth and uterine adenomyosis among four strains of mice.
    Nagasawa H; Naito T; Mori T
    In Vivo; 1988; 2(2):171-5. PubMed ID: 2979835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro hormonal requirement for lobulo-alveolar development in the mammary gland of high tumour albino mouse ICRC.
    Ranadive KJ; Gadkari SV; Chapekar TN
    Indian J Exp Biol; 1972 Sep; 10(5):327-32. PubMed ID: 4658181
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis.
    Medina D; Kittrell FS
    Cancer Res; 2003 Oct; 63(19):6140-3. PubMed ID: 14559792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin and murine mammary tumorigenesis: a review.
    Welsch CW; Nagasawa H
    Cancer Res; 1977 Apr; 37(4):951-63. PubMed ID: 191183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.
    Cheung SY; Yuen MT; Choi HL; Cheng HK; Huang Y; Chen S; Chan FL
    Int J Oncol; 2003 Jun; 22(6):1383-95. PubMed ID: 12739009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of neonatal androgenization on mammary gland mitotic rate and susceptibility of carcinogen-induced mammary dysplastigenesis and tumorigenesis in LEW/Mai rats.
    Purnell DM
    Am J Pathol; 1980 May; 99(2):463-74. PubMed ID: 6769336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.
    Tsubura A; Uehara N; Matsuoka Y; Yoshizawa K; Yuri T
    In Vivo; 2008; 22(2):191-201. PubMed ID: 18468403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice.
    Lopez J; Ogren L; Verjan R; Talamantes F
    Teratology; 1988 Aug; 38(2):129-34. PubMed ID: 3175946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.